| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 原料药(元) | 663,463,946.02 | 1,297,701,085.15 | 667,437,847.40 | 1,296,126,045.38 | 742,930,247.28 |
| 制剂药销售(元) | 1,316,372,595.81 | 2,929,101,286.64 | 1,515,645,735.41 | 3,408,377,279.45 | 1,956,757,186.13 |
| 其他(元) | 1,872,771,584.58 | 3,275,752,537.44 | 1,985,432,892.38 | 3,538,671,696.83 | 1,806,698,401.19 |
| 营业成本(元) | |||||
| 原料药(元) | 281,239,588.13 | 439,802,210.62 | 250,333,510.46 | 443,382,671.96 | 282,881,564.54 |
| 制剂药销售(元) | 506,335,651.54 | 1,176,996,571.88 | 592,013,863.24 | 1,261,112,304.74 | 655,936,129.61 |
| 其他(元) | 1,727,594,147.08 | 2,979,667,497.02 | 1,848,713,337.50 | 3,185,700,611.20 | 1,631,598,719.26 |
| 毛利(元) | |||||
| 原料药(元) | 382,224,357.89 | 857,898,874.53 | 417,104,336.94 | 852,743,373.42 | 460,048,682.74 |
| 制剂药销售(元) | 810,036,944.27 | 1,752,104,714.76 | 923,631,872.17 | 2,147,264,974.71 | 1,300,821,056.52 |
| 其他(元) | 145,177,437.50 | 296,085,040.42 | 136,719,554.88 | 352,971,085.63 | 175,099,681.93 |
| 毛利率(%) | |||||
| 原料药(%) | 57.61 | 66.11 | 62.49 | 65.79 | 61.92 |
| 制剂药销售(%) | 61.54 | 59.82 | 60.94 | 63.00 | 66.48 |
| 其他(%) | 7.75 | 9.04 | 6.89 | 9.97 | 9.69 |
| 收入构成(%) | |||||
| 原料药(%) | 17.22 | 17.30 | 16.01 | 15.72 | 16.49 |
| 制剂药销售(%) | 34.17 | 39.04 | 36.36 | 41.35 | 43.42 |
| 其他(%) | 48.61 | 43.66 | 47.63 | 42.93 | 40.09 |
| 毛利构成(%) | |||||
| 原料药(%) | 28.58 | 29.52 | 28.23 | 25.43 | 23.76 |
| 制剂药销售(%) | 60.57 | 60.29 | 62.52 | 64.04 | 67.19 |
| 其他(%) | 10.85 | 10.19 | 9.25 | 10.53 | 9.04 |